Latest Price Targets from the World's Best Analysts & Research Firms
| Analyst & Firm | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
B
11151
Barclays
Luke Sergott
|
Sotera Health
SHC
$4.49B
| $15.81 | $13 |
18%
downside
| Overweight |
24 Jun ‘25
2 months ago |
|
|
MR
11152
Melius Research
Ben Reitzes
|
Advanced Micro Devices
AMD
$253B
| $155.82 | $175 |
12%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
|
B
11153
Barclays
Luke Sergott
|
Danaher
DHR
$139B
| $194.33 | $225 |
16%
upside
| Overweight |
24 Jun ‘25
2 months ago |
|
|
LP
11154
Leerink Partners
Andrew Berens
|
Nuvalent
NUVL
$5.68B
| $78.73 | $140 |
78%
upside
| Outperform |
24 Jun ‘25
2 months ago |
|
|
HW&C
11155
HC Wainwright & Co.
Swayampakula Ramakanth
|
Nuvalent
NUVL
$5.68B
| $78.73 | $130 |
65%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
|
RC
11156
RBC Capital
Ashish Sabadra
|
Factset
FDS
$14.1B
| $372.86 | $503 |
35%
upside
| Sector Perform |
24 Jun ‘25
2 months ago |
|
|
TC
11157
TD Cowen
John Blackledge
|
Lyft
LYFT
$7.63B
| $18.39 | $21 |
14%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
|
S
11158
Susquehanna
Bascome Majors
|
CSX Corp
CSX
$60B
| $32.20 | $35 |
9%
upside
| Neutral |
24 Jun ‘25
2 months ago |
|
|
RC
11159
RBC Capital
Brian Abrahams
|
Cidara Therapeutics
CDTX
$1.6B
| $62.96 | $75 |
19%
upside
| Outperform |
24 Jun ‘25
2 months ago |
|
|
RC
11160
Roth Capital
Eric Handler
|
Electronic Arts
EA
$41.5B
| $166.04 | $185 |
11%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
|
JS
11161
JMP Securities
Devin Ryan
|
Capital Southwest
CSWC
$1.27B
| $22.91 | $25 |
9%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
RJ
11162
Raymond James
Buck Horne
|
Essex Property Trust
ESS
$17.3B
| $268.86 | $315 |
17%
upside
| Outperform |
24 Jun ‘25
2 months ago |
|
|
O
11163
Oppenheimer
Jeff Jones
|
ArriVent BioPharma
AVBP
$804M
| $19.82 | $44 |
122%
upside
| Outperform |
24 Jun ‘25
2 months ago |
|
|
O
11164
Oppenheimer
Brian Schwartz
|
Braze
BRZE
$3.48B
| $31.31 | $38 |
21%
upside
| Outperform |
24 Jun ‘25
2 months ago |
|
|
JS
11165
JMP Securities
Devin Ryan
|
Nuveen Churchill Direct Lending
NCDL
$779M
| $15.77 | $18 |
14%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
JS
11166
JMP Securities
Matthew Condon
|
PennantPark Floating Rate Capital
PFLT
$1.01B
| $10.18 | $11 |
8%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
JS
11167
JMP Securities
Matthew Condon
|
Trade Desk
TTD
$25.6B
| $52.40 | $100 |
91%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
U
11168
UBS
John Lovallo
|
KB Home
KBH
$4.49B
| $65.92 | $80 |
21%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
|
JS
11169
JMP Securities
Jonathan Wolleben
|
Skye Bioscience
SKYE
$128M
| $4.12 | $15 |
264%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
JM
11170
JP Morgan
Ken Goldman
|
Campbell Soup
CPB
$10.1B
| $33.74 | $34 |
1%
upside
| Neutral |
24 Jun ‘25
2 months ago |
|
|
JS
11171
JMP Securities
Reni Benjamin
|
Sana Biotechnology
SANA
$767M
| $3.02 | $5 |
66%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
U
11172
UBS
William Appicelli
|
FirstEnergy
FE
$25B
| $43.36 | $44 |
1%
upside
| Neutral |
24 Jun ‘25
2 months ago |
|
|
JS
11173
JMP Securities
Jason Butler
|
GH Research
GHRS
$832M
| $13.42 | $39 |
191%
upside
| Market Outperform |
24 Jun ‘25
2 months ago |
|
|
M
11174
Mizuho
Dan Dolev
|
Accenture
ACN
$157B
| $251.99 | $348 |
38%
upside
| Outperform |
24 Jun ‘25
2 months ago |
|
|
JM
11175
JP Morgan
DS Kim
|
New Oriental
EDU
$8.51B
| $52.05 | $62 |
19%
upside
| Overweight |
24 Jun ‘25
2 months ago |
|